Skip to main content

Table 4 PS and side effects

From: Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer

Characteristics

Treatment group (n = 21)

Control group (n = 59)

Grade 1–2

Grade 3

Grade 4

Grade 1–2

Grade 3

Grade 4

Fever

5 (23.8 %)

0

0

13 (22.0 %)

0

0

Anorexia

3 (14.3 %)

0

0

6 (10.2 %)

0

0

Allergy

1 (4.8 %)

0

0

0

0

0

Nausea, vomiting

3 (14.3 %)

0

0

9 (15.3 %)

0

0

Heart function

0

0

0

0

0

0

Liver function

0

0

0

0

0

0

Renal function

0

0

0

0

0

0

Myelosuppression

2 (9.5 %)

0

0

8 (13.6 %)

0

0

Radiation pneumonitis

4 (19.0 %)

3(14.3 %)

0

11 (18.6 %)

9(15.3 %)

0

PS change after TRT

0.48 ± 0.7*

0.9 ± 0.7

  1. *PS change is significantly better than control group (P < 0.05)